188 related articles for article (PubMed ID: 12495547)
21. Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration.
Chen H; Mou D; Du D; Chang X; Zhu D; Liu J; Xu H; Yang X
Int J Pharm; 2007 Aug; 341(1-2):78-84. PubMed ID: 17570625
[TBL] [Abstract][Full Text] [Related]
22. Enhancement and mechanism of transdermal absorption of terpene-induced propranolol hydrochloride.
Cui Y; Li L; Zhang L; Li J; Gu J; Gong H; Guo P; Tong W
Arch Pharm Res; 2011 Sep; 34(9):1477-85. PubMed ID: 21975809
[TBL] [Abstract][Full Text] [Related]
23. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
[TBL] [Abstract][Full Text] [Related]
24. Microemulsions as transdermal drug delivery vehicles.
Kogan A; Garti N
Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
[TBL] [Abstract][Full Text] [Related]
25. The release dynamics of model drugs from the psyllium and N-hydroxymethylacrylamide based hydrogels.
Singh B; Chauhan GS; Sharma DK; Kant A; Gupta I; Chauhan N
Int J Pharm; 2006 Nov; 325(1-2):15-25. PubMed ID: 16844329
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of microcrystalline chitosan properties as a drug carrier. Part II. The influence of microcrystalline chitosan on release rate of ketoprofen.
Bodek KH
Acta Pol Pharm; 2001; 58(3):185-94. PubMed ID: 11712735
[TBL] [Abstract][Full Text] [Related]
27. Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride.
Thacharodi D; Rao KP
Biomaterials; 1995 Jan; 16(2):145-8. PubMed ID: 7734649
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and pH sensitivity of carboxymethyl chitosan-based polyampholyte hydrogels for protein carrier matrices.
Chen L; Tian Z; Du Y
Biomaterials; 2004 Aug; 25(17):3725-32. PubMed ID: 15020148
[TBL] [Abstract][Full Text] [Related]
29. Sugar-mediated chitosan/poly(ethylene glycol)-beta-dicalcium pyrophosphate composite: mechanical and microstructural properties.
Wang JW; Hon MH
J Biomed Mater Res A; 2003 Feb; 64(2):262-72. PubMed ID: 12522813
[TBL] [Abstract][Full Text] [Related]
30. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
[TBL] [Abstract][Full Text] [Related]
31. Acrylic/cyclodextrin hydrogels with enhanced drug loading and sustained release capability.
Siemoneit U; Schmitt C; Alvarez-Lorenzo C; Luzardo A; Otero-Espinar F; Concheiro A; Blanco-Méndez J
Int J Pharm; 2006 Apr; 312(1-2):66-74. PubMed ID: 16464549
[TBL] [Abstract][Full Text] [Related]
32. A novel in situ gel for sustained drug delivery and targeting.
Ganguly S; Dash AK
Int J Pharm; 2004 May; 276(1-2):83-92. PubMed ID: 15113617
[TBL] [Abstract][Full Text] [Related]
33. Silicate cross-linked bio-nanocomposite hydrogels from PEO and chitosan.
Jin Q; Schexnailder P; Gaharwar AK; Schmidt G
Macromol Biosci; 2009 Oct; 9(10):1028-35. PubMed ID: 19593783
[TBL] [Abstract][Full Text] [Related]
34. Biocompatibility testing of chitosan hydrogels.
Cheburu CN; Stoica B; Neamţu A; Vasile C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):864-70. PubMed ID: 22046800
[TBL] [Abstract][Full Text] [Related]
35. Simulation of skin permeability in chitosan membranes.
Dureja H; Tiwary AK; Gupta S
Int J Pharm; 2001 Feb; 213(1-2):193-8. PubMed ID: 11165107
[TBL] [Abstract][Full Text] [Related]
36. Polysaccharide gels based on chitosan and modified starch: structural characterization and linear viscoelastic behavior.
Serrero A; Trombotto S; Cassagnau P; Bayon Y; Gravagna P; Montanari S; David L
Biomacromolecules; 2010 Jun; 11(6):1534-43. PubMed ID: 20507059
[TBL] [Abstract][Full Text] [Related]
37. PEG-stabilized carbodiimide crosslinked collagen-chitosan hydrogels for corneal tissue engineering.
Rafat M; Li F; Fagerholm P; Lagali NS; Watsky MA; Munger R; Matsuura T; Griffith M
Biomaterials; 2008 Oct; 29(29):3960-72. PubMed ID: 18639928
[TBL] [Abstract][Full Text] [Related]
38. Design and evaluation of a bioadhesive film for transdermal delivery of propranolol hydrochloride.
Rasool BK; Aziz US; Sarheed O; Rasool AA
Acta Pharm; 2011 Sep; 61(3):271-82. PubMed ID: 21945906
[TBL] [Abstract][Full Text] [Related]
39. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
[TBL] [Abstract][Full Text] [Related]
40. Transport of small anionic and neutral solutes through chitosan membranes: dependence on cross-linking and chelation of divalent cations.
da Silva RM; Caridade SG; San Román J; Mano JF; Reis RL
Biomacromolecules; 2008 Aug; 9(8):2132-8. PubMed ID: 18651769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
